{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:32:29Z","timestamp":1757611949220,"version":"3.44.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Several studies suggest that C-peptide (CP) is involved in regulating lipolysis, adipokine release, and other functions in the adipose tissue. On the other hand, organ-specific adipose tissues, such as the epicardial adipose tissue (EAT), have been reported as an independent cardiovascular risk factor in patients on dialysis. This study aimed to evaluate the association between CP, EAT volume, and coronary artery calcification (CAC) as markers of cardiovascular risk, on subjects with type 2 diabetes receiving insulin and dialysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective study on 62 patients with chronic kidney disease (CKD) stage 5 on dialysis awaiting kidney transplantation and referred for cardiovascular risk stratification at the Emory University Hospital. Computed tomography (CT) was used to assess CAC and to measure EAT volume. Demographic and anthropometric data were collected from all patients through record review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean patient age was 43\u202f\u00b1\u202f11 and 55% were women. None of the serum analytical parameters correlated with CP. Subjects with higher BMI exhibited higher levels of CP. EAT volume strongly correlated with CP levels, and it was significantly correlated with CAC. On the contrary, no correlation was found between CP and CAC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The significant association between EAT volume and CP suggests a potential role of CP in the cardiovascular physiopathology of patients with ESKD on dialysis. Insufficient statistical power was probably the cause of the lack of association of CP with CAC. Observational prospective studies are required to characterize CP as a cardiovascular risk marker in patients with ESKD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1650859","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:34Z","timestamp":1756964014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["C-peptide and epicardial adipose tissue in dialysis-dependent chronic kidney disease patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Luis","family":"D\u2019Marco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Checa-Ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Locascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owahabanun","family":"Joshua Okojie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Viejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valmore","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Karohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","article-title":"The impact of insulin resistance on the kidney and vasculature","volume":"12","author":"Artunc","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.33549\/physiolres.934519","article-title":"Insights into the physiology of C-peptide","volume":"69","author":"Vejrazkova","year":"2020","journal-title":"Physiol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2337\/db12-0293","article-title":"C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species\u2013mediated transglutaminase 2 activation","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/JOE-16-0349","article-title":"C-peptide protects against hyperglycemic memory and vascular endothelial cell apoptosis","volume":"231","author":"Bhatt","year":"2016","journal-title":"J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"162802","DOI":"10.5402\/2012\/162802","article-title":"C-peptide reduces mitochondrial superoxide generation by restoring complex i activity in high glucose-exposed renal microvascular endothelial cells","volume":"2012","author":"Vejandla","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.2337\/db13-0039","article-title":"C-peptide activates AMPK\u03b1 and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.3390\/jcm13237351","article-title":"Identification of adipsin as a biomarker of beta cell function in patients with type 2 diabetes","volume":"13","author":"Park","year":"2024","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0032-1323764","article-title":"Proinsulin C-peptide inhibits lipolysis in diabetic rat adipose tissue through phosphodiestrase-3B enzyme","volume":"45","author":"Ghorbani","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7150\/ijms.14110","article-title":"Interdependencies among selected pro-inflammatory markers of endothelial dysfunction, C-peptide, anti-inflammatory interleukin-10 and glucose metabolism disturbance in obese women","volume":"13","author":"Janowska","year":"2016","journal-title":"Int J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/oby.21137","article-title":"Peptide modifies leptin and visfatin secretion in human adipose tissue","volume":"23","author":"Garcia-Serrano","year":"2015","journal-title":"Obesity"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4239\/wjd.v6.i1.145","article-title":"Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus","volume":"6","author":"Ghorbani","year":"2015","journal-title":"World J Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/joim.12522","article-title":"C-peptide antioxidant adaptive pathways in \u03b2 cells and diabetes","volume":"281","author":"Luppi","year":"2017","journal-title":"J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1556\/2060.104.2017.2.2","article-title":"Physiological effects of proinsulin-connecting peptide in human subcutaneous adipose tissue","volume":"104","author":"Ghorbani","year":"2017","journal-title":"Physiol Int"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.diabet.2019.04.004","article-title":"Association of C-peptide with diabetic vascular complications in type 2 diabetes","volume":"46","author":"Wang","year":"2020","journal-title":"Diabetes Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4093\/dmj.2011.35.1.41","article-title":"Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients","volume":"35","author":"Kim","year":"2011","journal-title":"Diabetes Metab J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/01.ATV.0000116027.81513.68","article-title":"C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro","volume":"24","author":"Marx","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s12350-013-9761-8","article-title":"Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue","volume":"20","author":"Karohl","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.arteri.2019.10.006","article-title":"Epicardial adipose tissue: a cardiovascular risk marker to evaluate in chronic kidney disease","volume":"32","author":"D\u2019Marco","year":"2020","journal-title":"Clin Invest Arterioscler"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/ndt\/gft264","article-title":"Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in new Dialysis trial","volume":"28","author":"D\u2019Marco","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4149\/BLL_2018_102","article-title":"Relationship of epicardial fat tissue thickness with oxidant biomarkers in chronic kidney disease","volume":"119","author":"Karatas","year":"2018","journal-title":"Bratisl Lek Listy"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.00890111","article-title":"The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis\/calcification syndrome in ESRD patients","volume":"6","author":"Turkmen","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1291537","DOI":"10.1155\/2016\/1291537","article-title":"Epicardial fat: physiological, pathological, and therapeutic implications","volume":"2016","author":"Salazar","year":"2016","journal-title":"Cardiol Res Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.5114\/aoms.2016.63259","article-title":"Clinical importance of epicardial adipose tissue","volume":"13","author":"Nagy","year":"2017","journal-title":"Arch Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","article-title":"Epicardial fat: properties, function and relationship to obesity","volume":"8","author":"Rabkin","year":"2007","journal-title":"Obes Rev"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0184723","DOI":"10.1371\/journal.pone.0184723","article-title":"Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes","volume":"12","author":"Murai","year":"2017","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e2200264","DOI":"10.1002\/mnfr.202200264","article-title":"Loss of visceral fat is associated with a reduction in inflammatory status in patients with metabolic syndrome","volume":"67","author":"Castro-Barquero","year":"2023","journal-title":"Mol Nutr Food Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11255-015-1175-x","article-title":"The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease","volume":"48","author":"Savu","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e70282","DOI":"10.14814\/phy2.70282","article-title":"Fasting plasma C-peptide correlates with body mass index, hsCRP, apolipoprotein B, and other atherogenic lipids in healthy individuals","volume":"13","author":"Whiss","year":"2025","journal-title":"Physiol Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e003201","DOI":"10.1136\/bmjdrc-2022-003201","article-title":"High levels of serum C-peptide are associated with a decreased risk for incident renal progression in patients with type 2 diabetes: a retrospective cohort study","volume":"11","author":"Yang","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ndt\/gfx018","article-title":"Impact of end-stage renal disease on glucose metabolism\u2014a matched cohort analysis","volume":"32","author":"Guthoff","year":"2017","journal-title":"Nephrol Dialysis Transplant"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.3390\/ijerph18105388","article-title":"Insulin withdrawal in diabetic kidney disease: what are we waiting for?","volume":"18","author":"Morillas","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/ki.2014.296","article-title":"Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes","volume":"87","author":"Papademetriou","year":"2015","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12882-016-0372-x","article-title":"Correction of metabolic acidosis improves insulin resistance in chronic kidney disease","volume":"17","author":"Bellasi","year":"2016","journal-title":"BMC Nephrol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2337\/dc06-2127","article-title":"A1C and survival in maintenance hemodialysis patients","volume":"30","author":"Kalantar-Zadeh","year":"2007","journal-title":"Diabetes Care"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1542-4758.2008.00256.x","article-title":"Glucose in the dialysate: historical perspective and possible implications?","volume":"12","author":"Sharma","year":"2008","journal-title":"Hemodial Int"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/embo-reports\/kve071","article-title":"Mechanisms of nutritional and hormonal regulation of lipogenesis","volume":"2","author":"Kersten","year":"2001","journal-title":"EMBO Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/ndt\/gfad009","article-title":"The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"38","author":"Rossing","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2337\/dc14-2883","article-title":"Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial","volume":"39","author":"Davies","year":"2016","journal-title":"Diabetes Care"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/jcm9040947","article-title":"GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists","volume":"9","author":"G\u00f3rriz","year":"2020","journal-title":"J Clin Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2337\/diab.44.7.845","article-title":"Estimation of \u03b2-cell sensitivity from intravenous glucose tolerance test c-peptide data: knowledge of the kinetics avoids errors in modeling the secretion","volume":"44","author":"Toffolo","year":"1995","journal-title":"Diabetes"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2337\/dc09-2110","article-title":"Insulin resistance predicts mortality in nondiabetic individuals in the U.S.","volume":"33","author":"Ausk","year":"2010","journal-title":"Diabetes Care"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e003152","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11883-013-0339-3","article-title":"C-peptide and its career from innocent bystander to active player in diabetic atherogenesis","volume":"15","author":"Lebherz","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.28982\/josam.847350","article-title":"Beta cell function as an assessment tool for cardiovascular risk in patients with metabolic syndrome","volume":"5","author":"Erman","year":"2021","journal-title":"J Surg Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3109\/0886022X.2011.599913","article-title":"Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients","volume":"33","author":"Tonbul","year":"2011","journal-title":"Ren Fail"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2012.10.061","article-title":"Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients","volume":"226","author":"Turan","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/ijms21030978","article-title":"Epicardial adipose tissue, adiponectin and leptin: a potential source of cardiovascular risk in chronic kidney disease","volume":"21","author":"D\u2019Marco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1543816","DOI":"10.3389\/fcvm.2025.1543816","article-title":"Detection of arterial remodeling using epicardial adipose tissue assessment from CT calcium scoring scan","volume":"12","author":"Lee","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcct.2025.01.007","article-title":"Prediction of obstructive coronary artery disease using coronary calcification and epicardial adipose tissue assessments from CT calcium scoring scans","volume":"19","author":"Lee","year":"2025","journal-title":"J Cardiovasc Comput Tomogr"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1650859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:35Z","timestamp":1756964015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1650859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":57,"alternative-id":["10.3389\/fmed.2025.1650859"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1650859","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1650859"}}